Adding vitamin D to standard tuberculosis treatment is not beneficial, finds study
BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2099 (Published 20 April 2015) Cite this as: BMJ 2015;350:h2099- Cheryl Travasso
- 1Mumbai
Supplementing conventional tuberculosis treatment with vitamin D does not shorten the time taken to clear the infection, a study conducted at 13 sites in Tamil Nadu, India, has found.
The study, published in The Lancet Infectious Diseases, found that although supplementation with a high dose of vitamin D seemed to be safe, it did not seem to be beneficial to patients with an active tuberculosis infection.1
Vitamin D has immunomodulatory effects, and previous in vitro experiments and trials have indicated its potential usefulness as an adjunct to tuberculosis therapy. In south India, people with active …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.